Application of verbascoside in treating and preventing type II diabetic nephropathy
A technology of acteoside and diabetes, which is applied in the field of medicine, and can solve the problems of application reports of drugs or health care products without acteoside diabetic kidney damage, low oral bioavailability, etc.
Inactive Publication Date: 2018-08-28
NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
View PDF3 Cites 4 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Experiments have shown that verbascoside undergoes multiple hydrolysis processes in the gastrointestinal tract before being absorbed into the blood, and then undergoes further phase I (redox) and / or phase II (glucuronic acid, sulfuric acid, methylation) metabolism, so Oral bioavailability of verbascoside in rats is low
At present, there is no application report of verbascoside in the preparation of drugs or health products for preventing or treating diabetic kidney damage
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0039] Example 1: Take 10 g of verbascoside, add auxiliary materials, and prepare it into tablets according to a conventional method.
Embodiment 2
[0040] Example 2: Take 10 g of verbascoside, add auxiliary materials, and prepare capsules according to conventional methods.
Embodiment 3
[0041] Example 3: Take 10 g of verbascoside, add auxiliary materials, and prepare an oral liquid according to a conventional method.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention relates to new application and a new action mechanism of verbascoside, in particular to application of verbascoside in the drugs for treating and preventing type II diabetic nephropathy,and the research on the protection function of the verbascoside for the type II diabetic nephropathy and the action mechanism thereof. Results show that the verbascoside can alleviate liver injury caused by high glucose and lower the serum creatinine, urea nitrogen and urinary microalbuminuria levels, the blood fat level (total cholesterol and triglyceride) and the fasting blood-glucose and bloodinsulin level of spontaneous diabetes db / db mice; TGF (Transforming Growth Factor)-beta 1 and the signal transduction protein Smad3 and Smad4 and alpha-SMA protein expression thereof in a kidney tissue are obviously lowered; meanwhile, the verbascoside can alleviate the liver injury caused by high glucose; HK-2 proliferation and EMT (pithelial-Mesenchymal Transition) formation can be inhibited. In conclusion, the verbascoside has an obvious protection function on the type II diabetic nephropathy, the action mechanism of the verbascoside is that the kidney protection function of the verbascoside is implemented through oxidative stress reaction regulation and control, TGF-beta / smad signaling channel inhibition and kidney fibrosis alleviation.
Description
technical field [0001] The invention belongs to the technical field of medicine, and specifically relates to the application of verbascoside in the preparation of medicines or health care products for preventing or treating diabetic kidney damage. Background technique [0002] Actascoside is a representative component of phenylethanol glycosides, widely distributed in a variety of plant families and genera such as Verbenaceae, Lamiaceae, Scrophulariaceae, Oleaceae, and Plantaceae. Generally speaking, verbascoside is composed of caffeic acid and hydroxytyrosol through ester and glycosidic bonds, and its sugar part is composed of rhamnose and glucose. Experiments have shown that verbascoside undergoes multiple hydrolysis processes in the gastrointestinal tract before being absorbed into the blood, and then undergoes further phase I (redox) and / or phase II (glucuronic acid, sulfuric acid, methylation) metabolism, so Oral bioavailability of verbascoside in rats is low. Accordi...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
IPC IPC(8): A61K31/7034A61P3/10A61P13/12
CPCA61K31/7034A61P3/10A61P13/12
Inventor 宿树兰段金廒钱大玮朱悦严辉戴新新
Owner NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com